- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06440681
Effects of Lifestyle Intervention in the Biological Aging in Prediabetes
Effects of a 6-month Lifestyle Intervention Program in the DNAm PhenoAge, SOST, and GDF15 Markers of Biological Aging in Adults With Prediabetes
Lifestyle modifications, including dietary changes and increased physical activity, play a crucial role in controlling complications to reduce or eliminate them. As well as controlling disturbances in biochemical markers such as DNAm PhenoAge, and signs of aging such as circulating sclerostin (SOST) and growth differentiation factor 15 (GDF15). This study seeks to address this dilemma by focusing on specific groups of elderly Saudis with prediabetes . Lifestyle changes in elderly Saudis with prediabetes show promise in reducing or eliminating complications. The potential insights derived from this research extend beyond academia, offering tangible benefits for clinical practice and public health
The proposed study will be implemented to achieve the following objective:
- To determine changes in DNAm PhenoAge of elderly Saudis with prediabetes who underwent a 6-month lifestyle modification program.
- To determine changes in other candidate senescence markers such as circulating sclerostin (SOST) and growth differentiation factor 15 (GDF15) of elderly Saudis with prediabetes who underwent a 6-month lifestyle modification program.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants will be received at all healthcare centers in Arar, Kingdom of Saudi Arabia. They will be informed about the lifestyle modification intervention programme. The interview will take place in a designated and prepared place.
If approved, informed consent is signed. The procedures begin with filling out questionnaires and basic assessments include anthropometric, blood pressure and blood pressure measurements. The anthropometric measurements will be performed by well-trained medical staff. Height (m) and weight (kg) will be measured in light clothing without shoes. Waist, hip, circumference (cm) will be measured using a standard tape measure. BMI will be calculated by dividing weight in kilograms by the square of height in metres. Your blood pressure will be measured at each visit after adequate rest.
Dietary intake will be assessed through a validated food frequency questionnaire. Assessments will be repeated twice (at baseline and 6 months) in both groups. Fasting blood samples will then be collected using a sterile blood collection device to perform blood tests for biological age using self-analyzers in the internal laboratory of the participating primary health care centers. Tests will include complete blood count, serum albumin, creatinine, fasting glucose, C-reactive protein, alkaline phosphatase and other markers of aging such as SOST and DGF-15. Through these tests, the DNAm PhenoAge will be calculated through an online platform (https://thrivous.com/pages/biological-age Calculator).
In light of the results, participants will be included or excluded, and participants included in the program will continue with us through follow-up with nutritional awareness. 500 participants will be involved and all participants will be advised to:
Weight loss (5% of basic weight), exercise (4 hours/week), moderate fat consumption, and a diet rich in fiber.
5- Participants will receive individual, detailed and ongoing nutritional counseling through the study dietitian every two weeks, and they will also be encouraged to participate in physical activities. Table The detailed intervention for both groups is shown below. The measurements and analyzes will be repeated a few months after the beginning, and based on this, the Lifestyle Modification Group (LMP) will be determined: those who agreed and followed the previous instructions and advice.
The control group (CG): They are those who did not receive health education or did not follow previous instructions or advice.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ahmed S Alenezi, PhD
- Phone Number: 00966505384985
- Email: 444105554@student.ksu.edu.sa
Study Contact Backup
- Name: Shaun B Sabico, M.D.PhD
- Phone Number: 00966114675939
- Email: ssabico@ksu.edu.sa
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Clinical diagnosis of pre-diabetes for all Saudis aged 30 years and above, males and females
- They must be able to exercise and be able to follow a diet
Exclusion Criteria
- Insulin-dependent diabetes and non-diabetic patients
- People with diseases that prevent them from participating and doing exercises
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Lifestyle Modification Group (LMP)
They are the people who will follow the lifestyle modification program, which is: Dietary counseling and monitoring: reduce fat intake (30% of total energy and saturated fat 10% of total energy) and increase fiber intake (15 g/1000 kcal) in the diet Physical activity: moderate exercise (150 minutes/week) |
Dietary counseling and monitoring: Reduce fat intake (30% of total energy and saturated fat 10% of total energy) and increase fiber intake (15 g/1000 kcal) in the diet. Participants will receive individual, detailed, ongoing nutritional counseling by the study dietitian every two weeks. Physical activity: Participants will also be encouraged to participate in physical activities. moderate exercise (150 minutes/week) |
|
Placebo Comparator: Control group (CG)
They are people who will not follow the lifestyle modification program or they did not know about this program
|
Dietary counseling and monitoring: Reduce fat intake (30% of total energy and saturated fat 10% of total energy) and increase fiber intake (15 g/1000 kcal) in the diet. Participants will receive individual, detailed, ongoing nutritional counseling by the study dietitian every two weeks. Physical activity: Participants will also be encouraged to participate in physical activities. moderate exercise (150 minutes/week) |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the rate of measurements of Age marker Albumin post intervention
Time Frame: 6 months
|
Change in Albumin (g/L)
|
6 months
|
|
Change in the rate of measurements of Age marker fasting glucose post intervention
Time Frame: 6 months
|
Change in fasting glucose (mmol/L)
|
6 months
|
|
Change in the rate of measurements of Age marker Creatinine post intervention
Time Frame: 6 months
|
Change in Creatinine (umol/L)
|
6 months
|
|
Change in the rate of measurements of Age marker C-Reactive Protein post intervention
Time Frame: 6 months
|
Change in C-Reactive Protein (mg/dL)
|
6 months
|
|
Change in the rate of measurements of Age marker Alkaline Phosphatase post intervention
Time Frame: 6 months
|
Change in Alkaline Phosphatase (U/L)
|
6 months
|
|
Change in the rate of measurements of Age marker White Blood Cell Count (WBC) post intervention
Time Frame: 6 months
|
Change in White Blood Cell Count (WBC) (10^3/uL)
|
6 months
|
|
Change in the rate of measurements of Age marker Lymphocyte post intervention
Time Frame: 6 months
|
Change in Lymphocyte (%)
|
6 months
|
|
Change in the rate of measurements of Age marker Mean Cell Volume (MCV) post intervention
Time Frame: 6 months
|
Change in Mean Cell Volume (MCV) (fL)
|
6 months
|
|
Change in the rate of measurements of Age marker Red Cell Distribution Width (RDW) post intervention
Time Frame: 6 months
|
Change in Red Cell Distribution Width (RDW) (%)
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the rate of measurements of Age marker SOST post intervention
Time Frame: 6 months
|
Change in SOST(pmol/L)
|
6 months
|
|
Change in the rate of measurements of Age marker GDF15 post intervention
Time Frame: 6 months
|
Change in GDF15 (10^3 pg/mL)
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Shaun B Sabico, M.D.PhD, King Saud University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB log Number:2024-8
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PreDiabetes
-
Shifa International HospitalRecruitingPrediabetes | Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) | Prediabetes or DiabetesPakistan
-
National Yang Ming UniversityRecruiting
-
Albert Einstein College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Clinical Nutrition Research Centre, SingaporeSingapore Institute for Clinical SciencesCompleted
-
Northwestern UniversityAllianceChicago; Erie Family Health CentersCompleted
-
Ohio UniversityTouro University, CaliforniaCompletedPreDiabetes
-
Chinese Association of Geriatric ResearchCompleted
-
Jeong-taek WooChonbuk National University Hospital; Samsung Medical Center; Pusan National... and other collaboratorsUnknown
-
Mayo ClinicRecruiting
Clinical Trials on Providing nutritional counselling
-
Bahir Dar UniversityCompletedQuality of Life | MalnutritionEthiopia
-
Cairo UniversityCompleted
-
University of JenaCompletedReduction of Cardiovascular Risk FactorsGermany
-
University of RijekaRecruitingInflammation | Metabolic Syndrome | Overweight and ObesityCroatia
-
Helsinki University Central HospitalUniversity of Helsinki; University of Eastern FinlandUnknownHead and Neck Squamous Cell CancerFinland
-
Samsung Medical CenterRecruitingGastric Cancer | GastrectomyKorea, Republic of
-
Susanna KunvikCity of Pori; City of Rauma; The Martha association of South West Finland; City... and other collaboratorsNot yet recruitingQuality of Life | Nutritional Status | Dietary Habits | Mental Well-being | Functional Capacity | Muscle StrenghFinland
-
Mebo Research, Inc.uBiome; AurametrixCompletedNutritional and Metabolic DiseasesUnited States, United Kingdom
-
Centre for Addiction and Mental HealthCompletedPsychotic IllnessesCanada
-
Abbott NutritionCompleted